Recombinant multi-species ELK3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ELK3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the ETS-domain transcription factor family and the ternary complex factor (TCF) subfamily. Proteins in this subfamily regulate transcription when recruited by serum response factor to bind to serum response elements. This protein is activated by signal-induced phosphorylation; studies in rodents suggest that it is a transcriptional inhibitor in the absence of Ras, but activates transcription when Ras is present. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
The Alternative Names of target: D430049E23Rik,ELK3,ERP,ETS domain-containing protein Elk-3,ETS-related protein ERP,ETS-related protein NET,Elk3,Erp,Etrp,NET,Net,SAP-2,SAP2,SRF accessory protein 2),Sap-2,Serum response factor accessory protein 2 (SAP-2

Target products collectionGo to ELK3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T91906-Ag-1/ GM-Tg-hg-T91906-Ag-2 Human ELK3 protein Human
GM-Tg-rg-T91906-Ag-1/ GM-Tg-rg-T91906-Ag-2 Rat ELK3 protein Rat
GM-Tg-mg-T91906-Ag-1/ GM-Tg-mg-T91906-Ag-2 Mouse ELK3 protein Mouse
GM-Tg-cynog-T91906-Ag-1/ GM-Tg-cynog-T91906-Ag-2 Cynomolgus/Rhesus macaque ELK3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T91906-Ag-1/ GM-Tg-felg-T91906-Ag-2 Feline ELK3 protein Feline
GM-Tg-cang-T91906-Ag-1/ GM-Tg-cang-T91906-Ag-2 Canine ELK3 protein Canine
GM-Tg-bovg-T91906-Ag-1/ GM-Tg-bovg-T91906-Ag-2 Bovine ELK3 protein Bovine
GM-Tg-equg-T91906-Ag-1/ GM-Tg-equg-T91906-Ag-2 Equine ELK3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T91906-Ag-1/ GM-Tg-hg-T91906-Ag-2; GM-Tg-rg-T91906-Ag-1/ GM-Tg-rg-T91906-Ag-2;
GM-Tg-mg-T91906-Ag-1/ GM-Tg-mg-T91906-Ag-2; GM-Tg-cynog-T91906-Ag-1/ GM-Tg-cynog-T91906-Ag-2;
GM-Tg-felg-T91906-Ag-1/ GM-Tg-felg-T91906-Ag-2; GM-Tg-cang-T91906-Ag-1/ GM-Tg-cang-T91906-Ag-2;
GM-Tg-bovg-T91906-Ag-1/ GM-Tg-bovg-T91906-Ag-2; GM-Tg-equg-T91906-Ag-1/ GM-Tg-equg-T91906-Ag-2
Products Name ELK3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ELK3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ELK3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.